[Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
Dahlin
Jan
J
Reumatologisk klinik H, H:S Bispebjerg Hospital, DK-2400 København NV. sfs01@bbh.hosp.dk
Sørensen
Søren Freiesleben
SF
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D025242:Spondylarthropathies / Q000188:drug therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D008727:Methotrexate